The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Molecular genetics of early-onset Alzheimer’s disease revisited
Open accessAbstract
As the discovery of the Alzheimer's disease (AD) genes, APP, PSEN1, and PSEN2, in families with autosomal dominant early-onset AD (EOAD), gene discovery in familial EOAD came more or less to a standstill. Only 5% of EOAD patients are carrying a pathogenic mutation in one of the AD genes or a apolipoprotein E (APOE) risk allele ε4, most of EOAD patients remain unexplained. Here, we aimed at summarizing the current knowledge of EOAD genetics and its role in ongoing approaches to understand the biology of AD and disease symptomatology as well as developing new therapeutics. Next, we explored the possible molecular mechanisms that might underlie the missing genetic etiology of EOAD and discussed how the use of massive parallel sequencing technologies triggered novel gene discoveries. To conclude, we commented on the relevance of reinvestigating EOAD patients as a means to explore potential new avenues for translational research and therapeutic discoveries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These rare mutations cause the aggregation of amyloid proteins, leading to the progression of early onset AD.”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [157]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“But it was until 1980s that three genes, including APP, PSEN1, and PSEN2, were found to be responsible for early onset AD.157”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [157]
Experimental — accuracy not yet measuredIn the citing paper
“PSEN2 mutations are much rarer, with only around 30 mutations identified in ADAD families [2].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“A majority of ADAD families carry a pathogenic mutation in one of three genes: APP, presenilin 1 (PSEN1), or presenilin 2 (PSEN2) [2, 33].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“To date, more than 50 highly penetrant mutations have been identified in APP [2].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“ADAD is very rare, accounting for less than <1% of all cases of AD [2, 31–33]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“While mutations in these genes are the most well-studied mutations associated with EOAD, it is estimated that a significant portion of EOAD remains unexplained genetically [2].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“Gene duplications of APP are well-known to cause AD, with as many as 25 duplications of variable length associated with AD in EOAD families [2]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“The large variability in the age at onset of AD symptoms even among families who share common pathogenic mutations [31]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citationStrittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Cited by
Sorted by citations
Items 301–400 of 617
Li, X., Cui, Y., Jing, D., Xie, K., Zhong, X.-L., Kong, Y., Wang, Y., Chu, M. K., Wang, C., & Wu, L. (2021) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000438 · Cited by 11
Hamaguchi, T., Kim, J. H., Hasegawa, A., Goto, R., Sakai, K., Ono, K., Itoh, Y., & Yamada, M. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01252-0 · Cited by 11
Recent Advances Towards Diagnosis and Therapeutic Fingerprinting for Alzheimer’s Disease
Pradhan, L. K., Sahoo, P. K., Chauhan, S., & Das, S. K. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02009-7 · Cited by 11
Gómez‐Tortosa, E., Baradaran‐Heravi, Y., Dillen, L., Choudhury, N. R., Agüero, P., Pérez‐Pérez, J., Koçoğlu, C., Sainz, M. J., Ruiz-González, A., Téllez, R., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12913 · Cited by 11
The Potential of a Stratified Approach to Drug Repurposing in Alzheimer’s Disease
Anderson, C., Bucholc, M., McClean, P. L., & Zhang, S. (2023) · Biomolecules · doi:10.3390/biom14010011 · Cited by 13
Luukkainen, L., Helisalmi, S., Kytövuori, L., Ahmasalo, R., Solje, E., Haapasalo, A., Hiltunen, M., Remes, A. M., & Krüger, J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181256 · Cited by 11
Genetic Variants Associated With Alzheimer Disease in the 22 Arab Countries
Al-Thani, H. F., Ahmad, M. N., Younes, S. N., & Zayed, H. (2021) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000447 · Cited by 11
Niu, F., Sharma, A., Wang, Z., Feng, L., Muresanu, D. F., Sahib, S., Tian, Z. R., Lafuente, J. V., Buzoianu, A. D., Nozari, A., et al. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.06.004 · Cited by 10
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer’s disease
Iaccarino, L., Llibre‐Guerra, J. J., McDade, E., Edwards, L., Gordon, B. A., Benzinger, T. L. S., Hassenstab, J. J., Kramer, J. H., Li, Y., Miller, B. L., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae159 · Cited by 11
Rizoska, B., Zachrisson, O., Appelkvist, P., Boström, E., Björklund, M., Rachalski, A., Gkanatsiou, E., Kylefjord, H., Söderberg, L., Nygren, P., et al. (2024) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2024.103950 · Cited by 10
Associations of Polygenic Risk Score for Late-Onset Alzheimer's Disease With Biomarkers
Li, Q., Lv, X., Jin, F., Liao, K., Gao, L., & Xu, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.849443 · Cited by 10
Biomarkers and Risk Assessment of Alzheimer’s Disease in Low- and Middle-Income Countries
Adewale, B. A., Coker, M. M., Ogunniyi, A. O., Kalaria, R. N., & Akinyemi, R. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221030 · Cited by 11
Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
Haut, F., Argyrousi, E. K., & Arancio, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010259 · Cited by 11
ApoE Genotype-Dependent Response to Antioxidant and Exercise Interventions on Brain Function
Chaudhari, K., Wong, J. M., Vann, P. H., Como, T., O’Bryant, S. E., & Sumien, N. (2020) · Antioxidants · doi:10.3390/antiox9060553 · Cited by 9
Hoogmartens, J., Hens, E., Engelborghs, S., Vandenberghe, R. R., Deyn, P. P. D., Cacace, R., Broeckhoven, C. V., Cras, P. P., Goeman, J., Crols, R., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.09.009 · Cited by 10
Self-citationThe predictive value of normal EEGs in dementia due to Alzheimer’s disease
Briels, C. T., Stam, C. J., Scheltens, P., & Gouw, A. A. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51339 · Cited by 9
S, H. S. G. N., Prasanna, V. L., Satish, K. S., Yergolkar, A. V., Krishnamurthy, M., Rajalekshmi, S. G., Radhika, K., & Burri, R. R. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101421 · Cited by 10
Andersen, O. M., Monti, G., Jensen, A. M. G., de Waal, M. W. J., Hulsman, M., Olsen, J. G., & Holstege, H. H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.27.524103 · Cited by 10
Holstege, H. H., de Waal, M. W. J., Tesi, N., van der Lee, S. J., de Geus, C. M., van Spaendonk, R. M. L., Vogel, M. J., Ahmad, S., Amin, N., Amouyel, P., et al. (2023) · medRxiv · doi:10.1101/2023.07.13.23292622 · Cited by 10
Miller, A., Desai, A., Roley, L. T., Goodwin, R. L., Imeh‐Nathaniel, A., & Nathaniel, T. I. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1052330 · Cited by 9
STIM Proteins: The Gas and Brake of Calcium Entry in Neurons
Skobeleva, K., Wang, G., & Kaznacheyeva, E. V. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-024-01272-5 · Cited by 9
Falla, D. S., Villegas‐Lanau, C. A., White, C. L., Serrano, G. E., Acosta‐Uribe, J., Mejía‐Cupajita, B., Villalba‐Moreno, N. D., Lu, P., Glatzel, M., Kofler, J., et al. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae122 · Cited by 16
Chauhan, P., Wadhwa, K., & Singh, G. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156109 · Cited by 12
Perez-Garcia, G., Bicak, M., Haure‐Mirande, J., Perez, G. M., Otero‐Pagan, A., Sosa, M. A. G., Gasperi, R. D., Sano, M. C., Barlow, C., Gage, F. H., et al. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137080 · Cited by 9
Non-human Primate Models of Alzheimer’s Disease
Li, Y., & Gu, B. J. (2023) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2023.00006 · Cited by 8
Eta-secretase-like processing of the amyloid precursor protein (APP) by the rhomboid protease RHBDL4
Penalva, Y. C. M., Paschkowsky, S., Recinto, S. J., Duchesne, A., Hammond, T., Spiegler, P., Jansen, G., Levet, C., Charron, F. M., Freeman, M., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107541 · Cited by 9
Nguyen, L., Ajredini, R., Guo, S., Romano, L. E. L., Tomas, R. F., Bell, L. R., Ranum, P. T., Zu, T., Báñez-Coronel, M., Kelley, C. P., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2416885122 · Cited by 8
Curcumin suppresses neuroinflammation to protect neurons by preventing NLRP3 inflammasome activation
Shi, Q., Zheng, Y., Wang, L., Xue, Y., & Yang, Y. (2021) · European Journal of Inflammation · doi:10.1177/20587392211058615 · Cited by 10
Arnal, M., Bini, G., Fernández‐Orth, D., Samaras, E. G., Kassis, M., Aisopos, F., Rambla, J., Paliouras, G., Garrard, P., Giambartolomei, C., et al. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12300 · Cited by 9
Tarozzi, M. E., Bartoletti‐Stella, A., Dall’Olio, D., Matteuzzi, T., Baiardi, S., Parchi, P., Castellani, G., & Capellari, S. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01173-4 · Cited by 12
Yavari, M., Ramalingam, L., Harris, B. N., Kahathuduwa, C. N., Chavira, A., Biltz, C., Mounce, L., Maldonado, K. A., Scoggin, S. O., Zu, Y., et al. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.01.030 · Cited by 8
Hao, M., Chu, J., Zhang, T., Yin, T., Gu, Y., Liang, W., Ji, W., Zhuang, J., Liu, Y., Gao, J., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01736 · Cited by 8
Retinal manifestations and their diagnostic significance in Alzheimer's disease
Abhyankar, S. D., Little, K., Stitt, A. W., & Bhatwadekar, A. D. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251361937 · Cited by 8
Targeted copy number variant identification across the neurodegenerative disease spectrum
Dilliott, A. A., Zhang, K. K., Wang, J., Abrahão, A., Binns, M. A., Black, S. E., BORRIE, M. J., Dowlatshahi, D. D., Finger, E. C., Fischer, C. E., et al. (2022) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1986 · Cited by 7
Bioinformatic prediction of the molecular links between Alzheimer’s disease and diabetes mellitus
Castillo-Velázquez, R., Martínez-Morales, F., Castañeda‐Delgado, J. E., García-Hernández, M. H., Herrera-Mayorga, V., Sánchez, F. A. P., Rivera, G., Rivas-Santiago, B. T., & Lara-Ramirez, E. E. (2023) · PeerJ · doi:10.7717/peerj.14738 · Cited by 8
Molecular mechanisms and genetics of Alzheimer’s disease
Öztan, G., & İşsever, H. (2023) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2023-0049 · Cited by 8
Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-β Pathology in APP/PS1 Mice
Lapeyre, L., Piret, J., Rhéaume, C., Pons, V., Uyar, O., Préfontaine, P., Rivest, S., & Boivin, G. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230746 · Cited by 10
Cao, D., Zhang, Y., Zhang, S., Li, J., Yang, Q., & Wang, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-77921-6 · Cited by 11
de Oliveira, L. C., & Faria, D. D. P. (2022) · Molecules · doi:10.3390/molecules27103244 · Cited by 10
Vöglein, J., Willem, M., Trambauer, J., Schönecker, S., Dieterich, M., Biskup, S., Giudici, C., Utz, K. S., Oberstein, T. J., Brendel, M., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.034 · Cited by 8
Dong, L., Li, J., Liu, C., Mao, C., Wang, J., Lei, D., Huang, X., Chu, S., Hou, B., Feng, F., et al. (2021) · Brain and Behavior · doi:10.1002/brb3.2373 · Cited by 7
Novel presenilin 1 mutation (p.F386I) in a Chinese family with early-onset Alzheimer's disease
Shea, Y. F., Chan, A. O.-K., Chu, L., Lee, S., Law, C. Y., See, C.-H., Yiu, K.-L., & Chiu, P. K. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.10.015 · Cited by 8
Jo, H., Kim, M., Park, S., Park, J. E., Cho, S. H., Kim, S. J., Jang, H., Jung, Y. H., Kim, J. P., Na, D. L., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190469 · Cited by 8
Can Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer?
Kovács, G. G. (2016) · Prion · doi:10.1080/19336896.2016.1228507 · Cited by 8
Clinical and metabolic imaging features of late‐onset and early‐onset posterior cortical atrophy
Isella, V., Licciardo, D., Nastasi, G., Impagnatiello, V., Ferri, F., Mapelli, C., Crivellaro, C., Musarra, M., Morzenti, S., Appollonio, I. M., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15520 · Cited by 6
Ferreira, M., Martins, T. S., Alves, S. R., Rosa, I. M., Vogelgsang, J. S., Hansen, N., Wiltfang, J., Silva, O. A. B. D. C. E., Vitorino, R. M. P., & Henriques, A. G. (2023) · PROTEOMICS · doi:10.1002/pmic.202200515 · Cited by 6
Evaluation of the Clinical Features Accompanied by the Gene Mutations
Eryılmaz, I. E., Bakar, M., Egelí, Ü., Çeçener, G., Yurdacan, B., Çolak, D. K., & Tunca, B. (2021) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000437 · Cited by 7
Miyoshi, E., Morabito, S., & Swarup, V. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105530 · Cited by 7
Τhe Greek Variant in APP Gene: The Phenotypic Spectrum of APP Mutations
Kalampokini, S., Georgouli, D., Patrikiou, E., Provatas, A., Valotassiou, V. J., Georgoulias, P., Spanaki, C., Hadjigeorgiou, G. M., & Xiromerisiou, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212355 · Cited by 7
Doğan, M., Eröz, R., Tecellioğlu, M., Gezdirici, A., Çevik, B., & Barış, İ. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220414101251 · Cited by 7
Mathioudakis, L., Dimovasili, C., Bourbouli, M., Latsoudis, H., Kokosali, E., Gouna, G., Vogiatzi, E., Basta, M., Kapetanaki, S., Panagiotakis, S., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.07.002 · Cited by 7
Emerging concepts towards a translational framework in Alzheimer’s disease
Cozachenco, D., Zimmer, E. R., & Lourenco, M. V. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105246 · Cited by 7
Csabán, D., Pentelényi, K., Toth-Bencsik, R., Illés, A., Grosz, Z., Gézsi, A., & Molnár, M. J. (2021) · Life · doi:10.3390/life11040321 · Cited by 7
Novel Rare SORL1 Variants in Early-Onset Dementia
Korpioja, A., Krüger, J., Koivuluoma, S., Pylkäs, K., Moilanen, V., Helisalmi, S., Hiltunen, M. O., & Remes, A. M. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210207 · Cited by 7
Genetic landscape of early-onset dementia in Hungary
Csabán, D., Illés, A., Toth-Bencsik, R., Balicza, P., Pentelényi, K., Molnár, V., Gézsi, A., Grosz, Z., Gál, A., Kovacs, T., et al. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06168-8 · Cited by 7
Wang, Z., Zhang, Q., Lin, J.-R., Jabalameli, M. R., Mitra, J., Nguyen, N., & Zhang, Z. (2020) · doi:10.21203/rs.3.rs-31864/v1 · Cited by 7
Falla, D. S., Villegas‐Lanau, C. A., White, C. L., Serrano, G. E., Acosta‐Uribe, J., Mejía‐Cupajita, B., Villalba‐Moreno, N. D., Lu, P., Glatzel, M., Kofler, J., et al. (2023) · medRxiv · doi:10.1101/2023.08.14.23294081 · Cited by 7
Redox modulation of the complement cascade contributes to synapse loss in Alzheimer's disease
Oh, C.-K., Wang, Y., & Lipton, S. A. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00707 · Cited by 6
PANoptosis: Potential Therapeutic Prospects in Alzheimer's Disease
Guo, Z., & Wan, Y. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70231 · Cited by 9
Neuroimmune dysregulation in Alzheimer's disease: Mechanisms and therapeutic strategies
He, H., Zhu, S., Zhang, C., Wang, H., Li, Y., & Qian, H. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103055 · Cited by 8
Faulstich, N. G., Omar, S. H., O’Brien, C., Ojo, D. T., Brewer, P. C., Nathaniel, E. I., Goodwin, R. L., Roley, L. T., Imeh‐Nathaniel, A., & Nathaniel, T. I. (2025) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2025.1601375 · Cited by 6
A Urinary Metabolomics Analysis Based on UPLC-MS and Effects of Moxibustion in APP/PS1 Mice
He, R., Liu, J., Huang, C., Liu, J., Cui, H., & Zhao, B. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201109091759 · Cited by 6
Sánchez-Hidalgo, A. C., Arias-Aragón, F., Romero-Barragán, M. T., Martín-Cuevas, C., Delgado-Garcia, J. M., Martínez-Mir, A., & Scholl, F. G. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113896 · Cited by 7
Hypothetical Strategies of Gene and Environmental Influence on Life Expectancy: A Brief Review
Farhud, D. D. (2022) · Iranian Journal of Public Health · doi:10.18502/ijph.v51i11.11156 · Cited by 6
Pan, X., Coban‐Akdemir, Z., Gao, R., Jiang, X., Sheynkman, G., Wu, E., Huang, J. H., Sahni, N., & Yi, S. S. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad030 · Cited by 6
The association of microbial infection and adaptive immune cell activation in Alzheimer’s disease
Clement, M. (2023) · Discovery Immunology · doi:10.1093/discim/kyad015 · Cited by 6
Jąkalski, M., Bruhn‐Olszewska, B., Rychlicka-Buniowska, E., Davies, H., Sarkisyan, D., Siedlar, M., Baran, J., Węglarczyk, K., Jaszczyński, J., Ryś, J., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05618-8 · Cited by 6
Liu, Y., Xiao, X., Liu, H., Liao, X., Zhou, Y., Weng, L., Zhou, L., Liu, X., Bi, X., Xu, T., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1013295 · Cited by 8
Mengel, D., Liu, L., Yamamoto, R., Zülow, S., Deuschl, C., Hermann, D. M., Zerr, I., Selkoe, D. J., & Dodel, R. C. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.07.002 · Cited by 7
The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
Porter, T., Gozt, A., Mastaglia, F. L., & Laws, S. M. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch15 · Cited by 6
Cook, N., Yang, C., Zeng, Y., Sivasankaran, S. K., Song, S., Talozzi, L., Western, D., Yang, C., Liu, Y., Guen, Y. L., et al. (2025) · medRxiv · doi:10.1101/2025.10.31.25339089 · Cited by 10
Integrative machine learning approach to risk prediction for dementia and Alzheimer’s disease
Stern, A., & Linial, M. (2025) · GeroScience · doi:10.1007/s11357-025-01828-x · Cited by 5
Environmental Factors and Risk of Early-Onset Dementia: A Population-Based Case-Control Study
Soncini, C., Chiari, A., Rothman, K. J., Martini, N., Cherubini, A., Despini, F., Costanzini, S., Girolamo, G. D., Tondelli, M., Vinceti, G., et al. (2025) · Neuroepidemiology · doi:10.1159/000549445 · Cited by 5
Titze‐de‐Almeida, R., Gomes, G. D. M. O., dos Santos, T. C., & Titze-de-Almeida, S. S. (2025) · Pharmaceuticals · doi:10.3390/ph19010026 · Cited by 5
Ray, N. R., Bradley, J. L., Yılmaz, E., Kızıl, Ç., Kurup, J. T., Martin, E. R., Klein, H., Kunkle, B. W., Bennett, D. A. A., Jager, P. L. D., et al. (2025) · PLoS Genetics · doi:10.1371/journal.pgen.1011631 · Cited by 5
Amyloid Beta Dynamics in Biological Fluids—Therapeutic Impact
Schreiner, T. G., & Popescu, B. O. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245986 · Cited by 5
Gan, J., Zhou, H., Liu, C., & Fang, L. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06602-5 · Cited by 5
Case of Autosomal Dominant Alzheimer Disease With Negative Findings From PiB-PET Examination
Sun, H., Wang, Y., Wang, Y., & Zeng, F. (2023) · Neurology Genetics · doi:10.1212/nxg.0000000000200119 · Cited by 5
In silico Characterization of Predominant Genes Involved in Early Onset of Alzheimer's Disease
Sachdeva, P., & Ahmad, F. (2021) · The Journal of Neurobehavioral Sciences · doi:10.4103/jnbs.jnbs_34_21 · Cited by 5
Martínez-Drudis, L., Bérard, M., Musiol, D., Rivest, S., & Oueslati, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39571 · Cited by 6
Gao, Y., Schedin‐Weiss, S., & Tjernberg, L. O. (2024) · Advanced technology in neuroscience . · doi:10.4103/atn.atn-d-24-00014 · Cited by 5
Wu, J., Wang, J., Xiao, Z., Lu, J., Ma, X., Zhou, X., Wu, Y., Liang, X., Zheng, L., Ding, D., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcaf015 · Cited by 6
Mécanismes, facteurs de risque et stratégies thérapeutiques dans la maladie d’Alzheimer
Maître, M., Klein, C., & Mensah‐Nyagan, A. G. (2017) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2016.12.006 · Cited by 5
Shea, Y. F., Chu, L., Lee, S., & Chan, A. O.-K. (2017) · Hong Kong Medical Journal · doi:10.12809/hkmj176845 · Cited by 5
Spontaneous Pisa syndrome in a patient with early-onset Alzheimer’s disease
Woo, K. A., Yoo, D., Ki, C., & Lee, J. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04160-3 · Cited by 5
Tortelli, R., Seripa, D., Zecca, C., Dell’Abate, M. T., Bisceglia, P., Barulli, M. R., Blasi, R. D., & Logroscino, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126215 · Cited by 4
Advances in artificial neural networks as a disease prediction tool
Taylor, M. A., Cl, B., Schoen, M. W., & Hoque, S. (2021) · Journal of Cancer Research & Therapy · doi:10.14312/2052-4994.2021-1 · Cited by 5
Hydrolysis and Dissolution of Amyloids by Catabodies
Meretoja, V. V., Paul, S., & Planque, S. A. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7180-0_9 · Cited by 5
Zhao, L., Zhang, Z., Rodríguez, S. M., Vardarajan, B. N., Renton, A. E., Goate, A., Mayeux, R. P., Wang, G. T., & Leal, S. M. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0703-z · Cited by 5
Fan, Y., Wang, X., Ling, Y., Wang, Q., ZHOU, X., Li, K., & ZHOU, C. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108475 · Cited by 4
D’Angiolini, S., Gugliandolo, A., Calì, G., & Chiricosta, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157303 · Cited by 4
Recent Advances and Future Directions in Alzheimer’s Disease Genetic Research
Stancheva, M., Toncheva, D. I., & Karachanak-Yankova, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167819 · Cited by 4
Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer’s disease
Andersen, O. M., de Waal, M. W. J., Monti, G., Tesi, N., Jensen, A. M. G., de Geus, C. M., van Spaendonk, R. M. L., Vogel, M. J., Ahmad, S., Amin, N., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00907-z · Cited by 15
Cary, G. A., Li, Q., Wiley, J. C., Paisie, C. A., Du, Y., Zoeller, E. L., Duong, D. M., Fu, H., Seyfried, N. T., Levey, A. I., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.71008 · Cited by 4
Hernández-Contreras, K. A., Martínez-Díaz, J. A., Hernández‐Aguilar, M. E., Herrera‐Covarrubias, D., Rojas-Durán, F., & Aranda-Abreu, G. E. (2021) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2021.10.007 · Cited by 4
Pathogen infection in Alzheimer’s disease: pathophysiology and therapeutic strategies
Xiong, M., Yu, H., Tian, Y., Meng, L., & Zhang, Z. (2023) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.32 · Cited by 4
Gibbons, G. S., Gould, H., Lee, V. M. ‐., Crowe, A., & Brunden, K. R. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104876 · Cited by 5
Al-Abdulraheem, Z., & Durdağı, S. (2023) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2023.108575 · Cited by 4
Precision medicines for the treatment of Alzheimer's disease
Kanthale, S. B., Kendre, P. N., Vibhute, S. K., Jain, S. P., & Tiwari, S. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00025-x · Cited by 4
Ushakova, V. M., Zorkina, Y., Abramova, O. V., Kuanaeva, R. M., Barykin, E. P., Vaneev, A. N., Timoshenko, R. V., Gorelkin, P. V., Erofeev, A., Zubkov, E. A., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14101042 · Cited by 5
Metadata
- Authors
- Cacace, R., Sleegers, K., & Van Broeckhoven, C.
- Affiliations
- University of Antwerp (BE)
- Neurodegenerative Brain Diseases group Department of Molecular Genetics VIB Antwerp Belgium
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2016-03-23
- Volume
- 12
- Issue
- 6
- Pages
- 733-748
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2306696647
- Cited by
- 617
- References
- 167
- Citations by year
- 2026: 34 · 2025: 71 · 2024: 60 · 2023: 90 · 2022: 85 · 2021: 88 · 2020: 61 · 2019: 49 · 2018: 35 · 2017: 32 · 2016: 11
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Alzheimer s & Dementia (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Fonds Wetenschappelijk Onderzoek
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- early-onset Alzheimer's disease, familial Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Apolipoproteins E, Humans, Models, Molecular, Molecular Biology, Mutation, Amyloid beta-Protein Precursor, Presenilin-1, Presenilin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
